Form 4: CONMED Corp Executive Peter K. Shagory Reports Stock Option Grant
SEC Form 4 Filing
Peter K. Shagory, EVP of Strategy & Corporate Development at CONMED Corp, reports the acquisition of 26,127 stock options.
Summary
- Peter K. Shagory, an executive at CONMED Corp, filed a Form 4 with the SEC.
- The filing reports the grant of 26,127 options to purchase common stock on March 3, 2025, at an exercise price of $58.33.
- These options were granted under the company's 2018 Long-Term Incentive Plan and vest in equal amounts over a five-year period.
- Following the transaction, Shagory directly owns 26,127 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock option grant, which is a neutral event. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates an equity-based compensation grant to a key executive, which is a common practice in publicly traded companies to align management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of earliest transaction (stock option grant) |
| 03/03/2035 | Expiration date of the stock options |
| 03/05/2025 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.